Science
Press Release: Dupixent Approved In The EU As The First And Only Medicine For Young Children With Eosinophilic Esophagitis
(MENAFN - GlobeNewsWire - Nasdaq) Dupixent approved in the EU as the first and only medicine for young children with eosinophilic esophagitis Approval based on phase 3 data showing significantly ...
By: menafn
- Nov 06 2024
- 0
- 0 Views
ONLY AVAILABLE IN PAID PLANS